|
Research Management and Support
|
RMS2011 [E]
|
$335,240,650
|
N/A
|
National Cancer Institute
|
|
Cancer Center Support Grant
|
5P30CA013696-38
|
$3,816,425
|
Abate-Shen, Cory
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Role of Physical Properties in Pharmacokinetics, Biodistribution and Tumor Uptake
|
5F31CA150566-02
|
$33,239
|
Adjei, Isaac
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
MMC, VICC & TSU: Partners in Eliminating Cancer Disparities ( 1 of 3)
|
1U54CA163069-01
|
$1,457,296
|
ADUNYAH, SAMUEL
|
MEHARRY MEDICAL COLLEGE
|
|
SHP2-Mediated Synergy Between EGFR/HER2 and Beta Catenin in Breast Oncogenesis
|
5R01CA124940-05
|
$243,000
|
AGAZIE, YEHENEW
|
WEST VIRGINIA UNIVERSITY
|
|
Participation in the Eastern Cooperative Oncology Group
|
5U10CA107868-08
|
$216,434
|
AISNER, JOSEPH
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
Targeting Endoplasmic Reticulum Stress Response for Cancer Therapy
|
1R01CA152312-01A1
|
$363,859
|
AKTAS, BERTAL
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
|
Estrogen Receptor Alpha Proteostasis in Breast Cancer
|
1R01CA159578-01A1
|
$323,075
|
Alarid, Elaine
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Prospective study of farmers and their families (Agricultural health study)
|
ZIA CP010119-02020
|
$797,394
|
Alavanja, Michael
|
DCEG (NCI)
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-33S1
|
$139,575
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-33S2
|
$75,000
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
5P30CA023074-33
|
$3,953,813
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Southeast Michigan Community Network Program
|
3U54CA153606-02S1
|
$45,000
|
ALBRECHT, TERRANCE
|
WAYNE STATE UNIVERSITY
|
|
Southeast Michigan Community Network Program
|
5U54CA153606-02
|
$779,584
|
ALBRECHT, TERRANCE
|
WAYNE STATE UNIVERSITY
|
|
Characterization of WWOX, the Cancer Gene Spanning FRA16D
|
5R01CA102444-07
|
$333,032
|
Aldaz, Claudio
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
The Role of Syndecan-1 in Mouse Mammary Neoplasia
|
5R01CA090877-09
|
$286,318
|
ALEXANDER, CAROLINE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Assessments of Multiple Breast Cancer Biomarkers with Dendritic MRI Probes
|
5K25CA129173-03
|
$131,282
|
Ali, Md
|
HENRY FORD HEALTH SYSTEM
|
|
Combined Acoustic Imaging and Viscoelastic Parameters Estimation in Breast Cancer
|
1R01CA148994-01A1
|
$423,873
|
Alizad, Azra
|
MAYO CLINIC
|
|
Multiplexed Measurement of Kinase Activity in Single Cancer Cells
|
5R01CA139599-03
|
$565,804
|
Allbritton, Nancy
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Inherited bone marrow failure syndromes study
|
ZIA CP010144-07130
|
$1,066,163
|
Alter, Blanche
|
DCEG (NCI)
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-42S1
|
$125,781
|
Altieri, Dario
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-42
|
$2,401,347
|
Altieri, Dario
|
WISTAR INSTITUTE
|
|
Rational Design and Clinical Development of Shepherdin: A Novel Anti-Cancer Agent
|
5R01CA118005-04
|
$340,960
|
Altieri, Dario
|
WISTAR INSTITUTE
|
|
Control of Apoptosis in Cancer by Survivin
|
7R01CA078810-14
|
$301,698
|
Altieri, Dario
|
WISTAR INSTITUTE
|
|
Epidemiology of Breast Cancer Subtypes in African American Women: a Consortium
|
1P01CA151135-01A1
|
$3,798,244
|
AMBROSONE, CHRISTINE
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Genome-Wide Predictors of Treatment-Related Toxicities
|
1R01CA139426-01A2
|
$892,235
|
Ambrosone, Christine
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
DNA Methylation: a Mechanism for Aggressive Breast Cancer in African-American Wom
|
5R01CA133264-02
|
$928,333
|
Ambrosone, Christine
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Novel Markers for Disease Outcome in Breast Cancer
|
ZIA BC 010887
|
$141,702
|
Ambs, Stefan
|
CCR (NCI)
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$891,092
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
PARP Inhibition to Treat Triple-Negative Breast Cancer Brain Metastases
|
1K23CA157728-01
|
$173,621
|
Anders, Carey
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Biobehavioral responses to cancer
|
5K05CA098133-07
|
$160,410
|
Andersen, Barbara
|
OHIO STATE UNIVERSITY
|
|
Is GLUT1 required for tumor growth and the Warburg Effect?
|
1R01CA138482-01A2
|
$181,829
|
ANDERSON, STEVEN
|
UNIVERSITY OF COLORADO DENVER
|
|
PI Signaling Role in Epithelial/Mesenchymal Transition
|
5R01CA104708-07
|
$288,391
|
ANDERSON, RICHARD
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Patterns of Patient Care in Appalachia
|
5R01CA140335-02
|
$431,378
|
ANDERSON, ROGER
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
|
SEER Special Studies
|
ZIA CP010183-10316
|
$147,853
|
Anderson, Bill
|
DCEG (NCI)
|
|
Entirely Carbohydrate Vaccine Constructs and Their Application in Probing Glycoim
|
1R01CA156661-01
|
$295,996
|
Andreana, Peter
|
WAYNE STATE UNIVERSITY
|
|
LEGACY: A cohort of youth in families from the Breast Cancer Family Registry
|
1R01CA138844-01A2
|
$327,195
|
Andrulis, Irene
|
MT SINAI HOSP-SAMUEL LUNENFELD RES INST
|
|
Evaluation of antiangiogenic role of EM011, a novel tubulin-binding agent
|
5R00CA131489-04
|
$241,529
|
Aneja, Ritu
|
GEORGIA STATE UNIVERSITY
|
|
TRAINING IN CANCER BIOLOGY AND TRANSPLANTATION
|
5T32CA009515-27
|
$615,630
|
APPELBAUM, FREDERICK
|
UNIVERSITY OF WASHINGTON
|
|
Tumor Suppressor Protein, p53
|
ZIA BC 005599
|
$323,127
|
Appella, Ettore
|
CCR (NCI)
|
|
Regulation and Function of WIP1 Phosphatase and its Role in Tumor Cells
|
ZIA BC 011197
|
$323,127
|
Appella, Ettore
|
CCR (NCI)
|
|
Exercise effects on melatonin and sleep in young women
|
5R21CA137242-02
|
$196,895
|
Arikawa, Andrea
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
Penn Center for Innovation in Personalized Breast Screening
|
1U54CA163313-01
|
$1,471,443
|
ARMSTRONG, KATRINA
|
UNIVERSITY OF PENNSYLVANIA
|
|
Racial Differences in BRCA1/2 Testing: Patients or Providers?
|
5R01CA133004-03
|
$544,308
|
ARMSTRONG, KATRINA
|
UNIVERSITY OF PENNSYLVANIA
|
|
Impact of Mortality Concerns on Cancer Risk Behavior
|
5R01CA096581-08
|
$253,019
|
ARNDT, JAMIE
|
UNIVERSITY OF MISSOURI-COLUMBIA
|
|
Bacterial genes and promoters potential in breast cancer therapy
|
3R21CA153152-02S1
|
$13,092
|
Arrach, Nabil
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
Bacterial genes and promoters potential in breast cancer therapy
|
3R21CA153152-02S2
|
$7,912
|
Arrach, Nabil
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
Bacterial genes and promoters potential in breast cancer therapy
|
3R21CA153152-03S1
|
$23,027
|
Arrach, Nabil
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
Bacterial genes and promoters potential in breast cancer therapy
|
3R21CA153152-03S2
|
$23,027
|
Arrach, Nabil
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
Bacterial genes and promoters potential in breast cancer therapy
|
5R21CA153152-03
|
$184,422
|
Arrach, Nabil
|
UNIVERSITY OF CALIFORNIA IRVINE
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|